Long-term outcome after percutaneous peripheral intervention vs medical treatment for patients with superficial femoral artery occlusive disease

Circulation Journal

Volumn 72, Issue 5, 2008, Pages 734-739

  Kamiya, Chizuko ^a   Sakamoto, Shingo ^a   Tamori, Yuiichi ^a   Yoshimuta, Tsuyoshi ^a   Higashi, Masahiro ^a   Tanaka, Ryoichi ^a   Akutsu, Koichi ^a   Takeshita, Satoshi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Angioplasty; Claudication; Peripheral vascular disease; Restenosis

Indexed keywords

ACETYLSALICYLIC ACID; BERAPROST; CILOSTAZOL; LIMAPROST; SARPOGRELATE; TICLOPIDINE; WARFARIN;

ADULT; AGED; ARTERY OCCLUSION; ARTERY PERFORATION; CEREBROVASCULAR DISEASE; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; DISEASE EXACERBATION; EMBOLISM; FEMALE; FOLLOW UP; GANGRENE; HOSPITAL READMISSION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIA; LIMB AMPUTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; RETROSPECTIVE STUDY; REVIEW; SKIN ULCER; STATISTICAL SIGNIFICANCE; SUPERFICIAL FEMORAL ARTERY; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; AMPUTATION; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; INTERMITTENT CLAUDICATION; KAPLAN-MEIERS ESTIMATE; MALE; MEDICAL RECORDS; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME;

EID: 44149112995     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.734     Document Type: Review

References (24)

1. Arai M, Misao Y, Nagai H, Kawasaki M, Nagashima K, Suzuki K, et al. Granulocyte colony-stimulating factor: A noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease. Circ J 2006; 70: 1093-1098.
2. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001; 344: 1608-1621.
3. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, et al. Leg symptoms in peripheral arterial disease: Associated clinical characteristics and functional impairment. JAMA 2001; 286: 1599-1606.
4. Saito Y, Sasaki K, Katsuda Y, Murohara T, Takeshita Y, Okazaki T, et al. Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease. Circ J 2007; 71: 1187-1192.
5. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain: A meta-analysis. JAMA 1995; 274: 975-980.
6. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113: e463-e654.
7. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354: 1879-1888.
8. Surowiec SM, Davies MG, Eberly SW, Rhodes JM, Illig KA, Shortell CK, et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 2005; 41: 269-278.
9. Conrad MF, Cambria RP, Stone DH, Brewster DC, Kwolek CJ, Watkins MT, et al. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: A contemporary series. J Vasc Surg 2006; 44: 762-769.
10. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD): TASC Working Group: TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000; 31: S1-S296.
11. Strecker EP, Boos IB, Gottmann D. Femoropopliteal artery stent placement: Evaluation of long-term success. Radiology 1997; 205: 375-383.
12. Jamsen TS, Manninen HI, Jaakkola PA, Matsi PJ. Long-term outcome of patients with claudication after balloon angioplasty of the femoropopliteal arteries. Radiology 2002; 225: 345-352.
13. Costanza MJ, Queral LA, Lilly MP, Finn WR. Hemodynamic outcome of endovascular therapy for TransAtlantic Inter-Society Consensus type B femoropopliteal arterial occlusive lesions. J Vasc Surg 2004; 39: 343-350.
14. Murray JG, Apthorp LA, Wilkins RA. Long-segment (> or = 10 cm) femoropopliteal angioplasty: Improved technical success and long-term patency. Radiology 1995; 195: 158-162.
15. van der Zaag ES, Legemate DA, Prins MH, Reekers JA, Jacobs MJ. Angioplasty or bypass for superficial femoral artery disease?: A randomised controlled trial. Eur J Vasc Endovasc Surg 2004; 28: 132-137.
16. Vroegindeweij D, Vos LD, Tielbeek AV, Buth J, van den Bosch HC. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: A comparative randomized study. Cardiovasc Intervent Radiol 1997; 20: 420-425.
17. Wilson S, Gelfand D, Jimenez J, Gordon I. Comparison of the results of percutaneous transluminal angioplasty and stenting with medical treatment for claudicants who have superficial femoral artery occlusive disease. Vascular 2006; 14: 81-87.
18. London NJ, Srinivasan R, Naylor AR, Hartshorne T, Ratliff DA, Bell PR, et al. Subintimal angioplasty of femoropopliteal artery occlusions: The long-term results. Eur J Vasc Surg 1994; 8: 148-155.
19. Muradin GS, Bosch JL, Stijnen T, Hunink MG. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: Meta-analysis. Radiology 2001: 221: 137-145.
20. Perkins JM, Collin J, Creasy TS, Fletcher EW, Morris PJ. Exercise training versus angioplasty for stable claudication: Long- and medium-term results of a prospective, randomised trial. Eur J Vasc Endovasc Surg 1996; 11: 409-413.
21. Whyman MR, Fowkes FG, Kerracher EM, Gillespie IN, Lee AJ, Housley E, et al. Is intermittent claudication improved by percutaneous transluminal angioplasty?: A randomized controlled trial. J Vasc Surg 1997; 26: 551-557.
22. Zdanowski Z, Albrechtsson U, Lundin A, Jonung T, Ribbe E, Thorne J, et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions?: A randomized controlled study. Int Angiol 1999; 18: 251-255.
23. Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: A multicenter prospective randomized study. J Vasc Interv Radiol 2001; 12: 23-31.
24. Grimm J, Muller-Hulsbeck S, Jahnke T, Hilbert C, Brossmann J, Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol 2001; 12: 935-942.